1. Costs and Effects of an Ambulatory Geriatric Unit (the AGe-FIT Study): A Randomized Controlled Trial
- Author
-
Jenny Alwin, Anne Ekdahl, Tiny Jaarsma, Jeanette Eckerblad, Per Carlsson, Barbro Krevers, Magnus Husberg, Mitra Unosson, Anna Milberg, and Ann-Britt Wiréhn
- Subjects
Male ,Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi ,Pediatrics ,medicine.medical_specialty ,endocrine system ,multimorbidity ,Cost-Benefit Analysis ,ambulatory geriatric care ,Psychological intervention ,Nursing(all) ,costs ,security ,Comprehensive geriatric assessment ,law.invention ,Interviews as Topic ,Quality of life (healthcare) ,Ambulatory care ,Randomized controlled trial ,law ,Cause of Death ,Ambulatory Care ,Medicine ,Humans ,Single-Blind Method ,Geriatric Assessment ,General Nursing ,Aged ,Aged, 80 and over ,Patient Care Team ,Sweden ,Medicine(all) ,business.industry ,Public health ,Health Policy ,Hazard ratio ,Health services research ,General Medicine ,Health Care Service and Management, Health Policy and Services and Health Economy ,Hospitalization ,randomized controlled trial ,Ambulatory ,Emergency medicine ,Quality of Life ,hospitalization ,Female ,Health Services Research ,Geriatrics and Gerontology ,business - Abstract
Objectives: To examine costs and effects of care based on comprehensive geriatric assessment (CGA) provided by an ambulatory geriatric care unit (AGU) in addition to usual care. Design: Assessor-blinded, single-center randomized controlled trial. Setting: AGU in an acute hospital in southeastern Sweden. Participants: Community-dwelling individuals aged 75 years or older who had received inpatient hospital care 3 or more times in the past 12 months and had 3 or more concomitant medical diagnoses were eligible for study inclusion and randomized to the intervention group (IG; n ¼ 208) or control group (CG; n ¼ 174). Mean age (SD) was 82.5 (4.9) years. Intervention: Participants in the IG received CGA-based care at the AGU in addition to usual care. Outcome measures: The primary outcome was number of hospitalizations. Secondary outcomes were days in hospital and nursing home, mortality, cost of public health and social care, participant’ sense of security in care, and health-related quality of life (HRQoL). Results: Baseline characteristics did not differ between groups. The number of hospitalizations did not differ between the IG (2.1) and CG (2.4), but the number of inpatient days was lower in the IG (11.1 vs 15.2; P ¼.035). The IG showed trends of reduced mortality (hazard ratio 1.51; 95% confidence interval [CI] 0.988e2.310; P ¼.057) and an increased sense of security in care interaction. No difference in HRQoL was observed. Costs for the IG and CG were 33,371£ (39,947£) and 30,490£ (31,568£; P ¼ .432). Conclusions and relevance: This study of CGA-based care was performed in an ambulatory care setting, in contrast to the greater part of studies of the effects of CGA, which have been conducted in hospital settings. This study confirms the superiority of this type of care to elderly people in terms of days in hospital and sense of security in care interaction and that a shift to more accessible care for older people with multimorbidity is possible without increasing costs. This study can aid the planning of future interventions for older people. Trial Registration: clinicaltrials.gov identifier: NCT01446757. 2015 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- Published
- 2015
- Full Text
- View/download PDF